Profile
Benito Munoz worked as a Director in Research Laboratories at Merck & Co., Inc. from 1999 to 2008.
He then worked as a Director in Medicinal Chemistry at The Broad Institute, Inc. from 2009 to 2013.
After that, he worked as a Director at Karyopharm Therapeutics, Inc. and as an Executive Vice President in Drug Discovery at Proteostasis Therapeutics, Inc. from 2016 to 2017.
Munoz holds a graduate degree from Brock University and a doctorate degree from the University of Toronto.
Former positions of Benito Munoz
Companies | Position | End |
---|---|---|
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2013-10-31 |
MERCK & CO., INC. | Corporate Officer/Principal | 2008-09-30 |
KARYOPHARM THERAPEUTICS INC. | Director/Board Member | - |
PROTEOSTASIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Benito Munoz
Brock University | Graduate Degree |
University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Private companies | 2 |
---|---|
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Benito Munoz